Legal Services

Legal Notices

Welcome to www.casmed.com (the "Site"). CAS Medical Systems, Inc. ("CASMED") provides this Site subject to the following notices, terms, and conditions. All notices, terms, and conditions on the Site are subject to change by CASMED at any time by posting the revised notice, terms, or condition on the Site. Your continued use of the Site following any such posting will be deemed as consent to the new notice, term, or condition. By using this Site you understand and agree to the terms outlined here, in the CASMED Terms of Service, and in the CASMED Privacy Policy.

Ownership of Content

All content contained on this Site, including but not limited to text, graphics, logos, button icons, images, audio clips, video clips, data, software, scripts, techniques, ideas, algorithms, concepts, user lists, and other materials and information (collectively, "Content"), is the property of CASMED or its suppliers, and is protected by U.S. and international copyright laws. The compilation (meaning the collection, arrangement, and assembly) of all Content on this Site is also the exclusive property of CASMED and is protected by U.S. and international copyright laws. The Content may only be used in conjunction with the authorized use of CASMED products and services. Any other use, including the reproduction, modification, distribution, transmission, republication, display, or performance of any of the Content is strictly prohibited.

Trademarks

Unless otherwise indicated, all trademarks or service marks (as applicable) listed on this Site are trademarks or service marks (as applicable) of CASMED or its licensors in the United States and other countries. All other trademarks are trademarks or registered trademarks of their respective owners. It is illegal to use any trademark, service mark, logo, and/or trade name of CASMED or its Affiliates without express permission. CASMED's trademarks or service marks may not be used in connection with any product or service that is not a product or service of CASMED, or in any manner that is likely to cause confusion among customers or that disparages or discredits CASMED.

Use of Site

No portion of this Site may be reproduced, duplicated, copied, sold, resold, or otherwise exploited for any purpose, commercial or otherwise, that is not expressly permitted in writing by CASMED.

Patents

The following list of patents is intended to serve as notice under 35 U.S.C. § 287.

7,072,701;  6,456,862 B2;  8,077,296; 8,396,526;  8,077,312;  7,047,054;  7,313,427;  8,428,674;  8,391,942; D694,133; 8,761,851; 8,897,848, 8,923,943.

Int’l Patents

1259791; 2003254135; 2,494,030; 4,465,271; 2006247746; 2010227077; 1885235; 5175179; 2,608,426.

Copyright Complaints

CASMED respects the intellectual property of others. If you believe that your work has been copied in a way that constitutes copyright infringement, please provide CASMED's Copyright Agent the following written information:

  • An electronic or physical signature of the person authorized to act on behalf of the owner of the copyright interest;
  • A description of the copyrighted work that you claim has been infringed upon;
  • A description of where the material that you claim is infringing is located on the Site;
  • Your address, telephone number, and e-mail address;
  • A statement by you that you have a good faith belief that the disputed use is not authorized by the copyright owner, its agent, or the law;
  • A statement by you, made under penalty of perjury, that the above information in your notice is accurate and that you are the copyright owner or authorized to act on the copyright owner's behalf.

CASMED's Copyright Agent for notice of claims of copyright infringement on its Site can be reached at copyright@casmed.com.

Conflict Minerals Policy Statement

CASMED is concerned by reports that profits from the sale of certain metals mined in the Democratic Republic of the Congo or adjoining countries (the “DRC Region”) may be directly or indirectly financing armed conflict in the DRC Region, resulting in significant environmental and human rights abuses.  Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Act”) enacted in July 2010 imposes new supply chain reporting requirements on publicly traded companies to promote transparency and consumer awareness regarding the use of “conflict minerals”, which are defined as columbite-tantalite (coltan), cassiterite, gold, wolframite, or their derivatives (tantalum, tin, and tungsten) or any other mineral or its derivatives determined by the U.S. Secretary of State to be financing conflict in the DRC Region. 

Rules adopted pursuant to Section 1502 of the Act require publicly traded companies to disclose whether they use conflict minerals that originated in the DRC Region and if so, to issue a report identifying their products that are not “conflict free” and their due diligence efforts to determine the source and chain of custody of the metals.  “Conflict free” means the product does not contain conflict metals that directly or indirectly finance or benefit armed groups in the DRC Region.   

CASMED is committed to ethical practices and to avoiding the use of any conflict minerals in its products which directly or indirectly finance or benefit armed groups in the DRC Region.  CASMED is further committed to complying with the reporting obligations required under Section 1502 of the Act as well as the related rules and regulations issued by the U.S. Securities and Exchange Commission and all other applicable laws and regulations wherever it conducts business.

In support of this effort:

CASMED will conduct inquiries into the source of any conflict minerals included in its products, and CASMED intends to utilize the Electronic Industry Citizenship Coalition Due Diligence- Global e-Sustainability Initiative Conflict Minerals Reporting Template to obtain chain of custody declarations from suppliers to ensure transparency and corporate social responsibility throughout its supply chain.

CASMED will not knowingly procure conflict minerals that originate from facilities in the DRC Region that are not certified as “conflict free”.

CASMED expects all of its suppliers to develop a conflict minerals policy, due diligence framework and management system and comply with all applicable aspects of the Act and its related rules and regulations.

CASMED will evaluate its relationships with its suppliers on an ongoing basis to ensure continued compliance with this policy and reserves the right to request additional documentation from its suppliers regarding the source of any conflict minerals included in its products. 

Disclaimer

THIS SITE IS PROVIDED BY CAS MEDICAL SYSTEMS, ON AN "AS IS" BASIS. CASMED MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, AS TO THE OPERATION OF THE SITE OR THE INFORMATION, CONTENT, MATERIALS, PRODUCTS OR SERVICES INCLUDED ON THIS SITE. TO THE FULL EXTENT PERMISSIBLE BY APPLICABLE LAW, CASMED DISCLAIMS ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. CASMED WILL NOT BE LIABLE FOR ANY DAMAGES OF ANY KIND ARISING FROM THE USE OF THIS SITE, INCLUDING BUT NOT LIMITED TO DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, AND CONSEQUENTIAL DAMAGES.

Applicable Law

This Site is created and controlled by CAS MEDICAL SYSTEMS in the State of Connecticut, USA. As such, the laws of the State of Connecticut will govern these notices, terms, and conditions, without giving effect to any principles of conflicts of laws.

Our Address

CAS Medical Systems, Inc.
44 East Industrial Road
Branford, CT 06405

CAS Medical Systems, Inc. Legal Notices • May 2007